Boiler manufacturers in india

Biotechnology Companies in India

  • 3rd biggest biotech industry in the Asia-Pacific region.
  • 2nd highest number of USFDA–approved plants.
  • USD 3.7 Billion to be spent on biotechnology from 2012-17.
  • No. 1 producer of Hepatitis B vaccine recombinant.
  • USD 4.3 Billion bio-economy by the end of 2013.
  • USD 100 Billion industry by 2025.


  • India is amongst the top 12 biotech destinations in the world and ranks third in the Asia-Pacific region.
  • India has the second-highest number of USFDA–approved plants, after the USA.
  • India adopted the product patent regime in 2005.
  • Increasing government expenditure will augment the growth of the sector — the government aims to spend USD 3.7 Billion on biotechnology between 2012-17.
  • India is the largest producer of recombinant Hepatitis B vaccine.
  • India has the potential to become a major producer of transgenic rice and several genetically modified (GM) or engineered vegetables.


  • The Indian biotech industry will grow at an average growth rate of around 30% a year and reach USD 100 Billion by 2025.
  • The Indian bio-economy grew to USD 4.3 Billion at the end of 2013, up from USD 530 Million in 2003.
  • The Indian biotech industry grew by 15.1% in 2012–13, increasing the market’s revenues from USD 3.31 Billion in 2011-12 to USD 3.81 Billion in 2012–13.
  • The market size of the sector is expected to rise up to USD 11.6 Billion by 2017 due to a range of factors such as growing demand for healthcare services, intensive R&D activities and strong government initiatives.
  • The Indian biotechnology sector is divided into five major segments — bio-pharma, bio-services, bio-agri, bio-industrial and bio-informatics.
  • The bio-pharmaceutical sector accounts for the largest share of the biotech industry with a share of 64% in total revenues in 2013, followed by bio-services (18%), bio-agri (14%), bio-industrial (3%) and bio-informatics (1%).
  • Revenue from bio-pharma exports reached USD 2.2 Billion in 2013, accounting for 51% of total revenues of the biotech industry.


  • The sector has seen high growth with a CAGR in excess of 20% and the key drivers for growth in the biotech sector are increasing investments, outsourcing activities, exports and the government’s focus on the sector.
  • A strong pool of scientists and engineers.
  • Cost-effective manufacturing capabilities.
  • The setting up of national research laboratories, centres of academic excellence in biosciences, several medical colleges, educational and training institutes offering degrees and diplomas in biotechnology, bio-informatics and biological sciences.
  • For global companies looking to economise, outsourcing to lower cost economies results in a cost arbitrage of more than 50%.
  • Fast-developing clinical capabilities with the country becoming a popular destination for clinical trials, contract research and manufacturing activities.


  • Foreign Direct Investment (FDI) up to 100% is permitted through the automatic route for greenfield and through the government route for brownfield, for pharmaceuticals.
Interesting facts
Related video
Dr. Mitra, Genova Biotech, Hyderabad, India
Dr. Mitra, Genova Biotech, Hyderabad, India
India vs Monsanto - seeds of discord
India vs Monsanto - seeds of discord
Indian Governement Files Biopiracy Lawsuit Against Monsanto
Indian Governement Files Biopiracy Lawsuit Against Monsanto
India: Farmers protest against genetically modified
India: Farmers protest against genetically modified ...
Symposium: Platform Companies in Biotechnology
Symposium: Platform Companies in Biotechnology
Pharmaceutical Companies in India
Pharmaceutical Companies in India
Related Posts